William Eden
Managing Director
William Eden has been involved in the life sciences industry for over 15 years,
taking companies from R&D through to late stage and exits. He led Peter
Thiel's life science investment team at Thiel Capital for 6 years, focusing on
seed to Series B rounds, and has been an angel investor for a decade. He worked
as an entrepreneur-in-residence with Errik Anderson, founder of Adimab, Alloy
Therapeutics, and Compass Therapeutics. Other experience included leading
analytics at a digital health startup, concierge medicine, and more. This broad
experience, from company stage to sub-sector within the industry, is critical
for meeting the diverse challenges of any life sciences startup.